0001104659-21-001032.txt : 20210105
0001104659-21-001032.hdr.sgml : 20210105
20210105171503
ACCESSION NUMBER: 0001104659-21-001032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201231
FILED AS OF DATE: 20210105
DATE AS OF CHANGE: 20210105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schroeder Theodore R
CENTRAL INDEX KEY: 0001378690
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37558
FILM NUMBER: 21507045
MAIL ADDRESS:
STREET 1: 12481 HIGH BLUFF DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nabriva Therapeutics plc
CENTRAL INDEX KEY: 0001641640
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 56 FITZWILLIAM SQUARE
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: (610) 816-6640
MAIL ADDRESS:
STREET 1: 1000 CONTINENTAL DRIVE
STREET 2: SUITE 600
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
FORMER COMPANY:
FORMER CONFORMED NAME: Nabriva Therapeutics AG
DATE OF NAME CHANGE: 20150507
4
1
tm211621-4_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2020-12-31
0
0001641640
Nabriva Therapeutics plc
NBRV
0001378690
Schroeder Theodore R
1000 CONTINENTAL DRIVE
SUITE 600
KING OF PRUSSIA
PA
19406
1
1
0
0
Chief Executive Officer
Ordinary Shares
2020-12-31
4
F
0
121
2.42
D
64518
D
The number of ordinary shares reported on this Form 4 reflects a 1-for-10 reverse stock split effected on December 3, 2020.
/s/ Robert Crotty, by power of attorney
2021-01-05